- Woke ideology is subverting biology.
- About 40 percent of those surveyed said they had delayed or gone without care in the last year because of the expense.
- Cassidy: Sanders is prioritizing partisan labor legislation (that will never pass the Senate) over bipartisan health legislation (that could pass. (InsideHealthPolicy – gated)
- Medicare reform failures: “While MACRA’s goal of moving Medicare beyond fee-for-service and towards paying for value was reasonable and broadly popular, its … alternative payment models have not fostered quality improvement … and … have also failed to deliver savings.”
- Effect of Lockdowns plus teacher unions: 13-year-olds record lowest test scores in decades.
Category: Policy & Legislation
Thursday Links
- A (somewhat weak) defense of eating animals.
- The US has been falling behind other countries in life expectancy. (77 vs 82 years for all high-income countries)
- Possible reasons: we have more deaths by car crashes, gun homicides, suicides and overdoses.
- George Halvorson: Medicare Advantage is saving money for the Medicare program – despite contrary claims.
- Americans are the biggest consumers of high fructose corn syrup in the world. The reason: sugar quotas make the price of sugar in the US really high.
Monday Links
- Chinese military had deep ties to Wuhan lab suspected of COVID-19 outbreak.
- The case for more competition in Medicare.
- A deep dive into the statistically weak case for veganism.
- 2022 was a record year for the number of solar energy projects that were rejected by rural communities in the United States.
- One good thing that came out of the Vietnam war (and about the only good thing I can think of): our best malaria drug.
- Medicare sets price for 10,000 doctor services. What happens when the prices are wrong? Doctors and hospitals have perverse incentives to over provide services with high reimbursement rates and under provide services with low rates.
Is Medicare Advantage the Answer to High Drug Costs?
Average annual deductibles in Part D prescription drug plans (PDPs) are roughly four times higher than those in Medicare Advantage drug plans (MA-PDs) ($398 versus $90). Average monthly premiums for PDPs are also roughly 3.5 times higher than in MA-PDPs ($40 versus $11). Similarly, MA-PDP formularies cover a higher share of potentially coverable Part D drugs than PDPs (89 percent compared to 83 percent). At the same time, MA-PDPs impose utilization management requirements (such as prior authorization and quantity limits) on formulary covered drugs at a lower rate, relative to PDPs.